Capecitabine plus oxaliplatin compared with fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: Final Results of the NO16968 randomized controlled phase III trial

Hans Joachim Schmoll, Josep Tabernero, Jean Maroun, Filippo De Braud, Timothy Price, Eric Van Cutsem, Mark Hill, Silke Hoersch, Karen Rittweger, Daniel G. Haller

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Capecitabine plus oxaliplatin compared with fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: Final Results of the NO16968 randomized controlled phase III trial'. Together they form a unique fingerprint.

Medicine & Life Sciences